Monofer (Ferric Derisomaltose)

Ferric derisomaltose, the active ingredient in Monofer, is an iron supplement presented as an intravenous solution for intravenous administration. It provides bioavailable iron for patients with iron deficiency anemia, including those with chronic kidney disease or postoperative blood loss, enabling rapid restoration of hemoglobin levels.

GNH USA supplies Monofer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and patient safety through rigorous quality control across global markets.

Monofer is used to treat iron deficiency anemia by replenishing iron stores via the intravenous route.

- Iron deficiency anemia: rapid correction of hemoglobin and replenishment of iron stores. - Chronic kidney disease‑related anemia: provides intravenous iron for patients on dialysis or with reduced oral absorption. - Peri‑operative or postpartum anemia: restores iron levels when rapid repletion is required.

Monofer may cause adverse reactions ranging from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal discomfort. - Headache: transient cranial pain. - Injection site reactions: erythema, pain or swelling at the infusion site. - Hypotension: transient drop in blood pressure during infusion.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring emergency treatment. - Hypersensitivity syndrome: rash, fever, eosinophilia. - Acute iron overload: signs of organ toxicity due to excess iron. - Thromboembolic events: rare clot formation.

Before using Monofer, consider the following precautions to ensure safe administration. - Assess iron status: confirm iron deficiency anemia and evaluate ferritin and transferrin saturation. - Monitor hemoglobin: check baseline and follow‑up levels to avoid excessive rise. - Screen for hypersensitivity: avoid use in patients with known allergy to ferric derisomaltose or other IV iron products. - Use with caution in cardiac disease: monitor for hypotension or arrhythmias during infusion. - Avoid in active infection: defer infusion until infection is controlled. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Monofer can interact with certain medicines, affecting iron metabolism or infusion safety.

Major Interactions (Avoid): - Erythropoiesis‑stimulating agents (ESAs): concurrent use may increase risk of hypertension and cardiovascular events. - High‑dose vitamin C: may enhance free iron release, increasing oxidative stress.

Moderate Interactions (Monitor Closely): - Oral iron supplements: may reduce absorption of ferric derisomaltose if given concurrently; separate administration times. - Antacids containing aluminum or magnesium: can affect iron complex stability; schedule apart from infusion. - Certain antibiotics (e.g., tetracyclines, fluoroquinolones): may chelate iron and reduce efficacy.